The global Antibody Drug Conjugates market was valued at 1622.24 Million USD in 2020 and will grow with a CAGR of 7.02% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC`s involves great difficulty, inspite of these hurdles recently approved ADC`s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC`s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
By Market Verdors:
F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals
By Types:
Adcetris
Kadcyla
By Applications:
Breast Cancer
Lymphoma
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Antibody Drug Conjugates Market Size Analysis from 2022 to 2027
1.5.1 Global Antibody Drug Conjugates Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Antibody Drug Conjugates Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Antibody Drug Conjugates Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Antibody Drug Conjugates Industry Impact
Chapter 2 Global Antibody Drug Conjugates Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antibody Drug Conjugates (Volume and Value) by Type
2.1.1 Global Antibody Drug Conjugates Consumption and Market Share by Type (2016-2021)
2.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2016-2021)
2.2 Global Antibody Drug Conjugates (Volume and Value) by Application
2.2.1 Global Antibody Drug Conjugates Consumption and Market Share by Application (2016-2021)
2.2.2 Global Antibody Drug Conjugates Revenue and Market Share by Application (2016-2021)
2.3 Global Antibody Drug Conjugates (Volume and Value) by Regions
2.3.1 Global Antibody Drug Conjugates Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Antibody Drug Conjugates Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Antibody Drug Conjugates Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Antibody Drug Conjugates Consumption by Regions (2016-2021)
4.2 North America Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
4.10 South America Antibody Drug Conjugates Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Antibody Drug Conjugates Market Analysis
5.1 North America Antibody Drug Conjugates Consumption and Value Analysis
5.1.1 North America Antibody Drug Conjugates Market Under COVID-19
5.2 North America Antibody Drug Conjugates Consumption Volume by Types
5.3 North America Antibody Drug Conjugates Consumption Structure by Application
5.4 North America Antibody Drug Conjugates Consumption by Top Countries
5.4.1 United States Antibody Drug Conjugates Consumption Volume from 2016 to 2021
5.4.2 Canada Antibody Drug Conjugates Consumption Volume from 2016 to 2021
5.4.3 Mexico Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 6 East Asia Antibody Drug Conjugates Market Analysis
6.1 East Asia Antibody Drug Conjugates Consumption and Value Analysis
6.1.1 East Asia Antibody Drug Conjugates Market Under COVID-19
6.2 East Asia Antibody Drug Conjugates Consumption Volume by Types
6.3 East Asia Antibody Drug Conjugates Consumption Structure by Application
6.4 East Asia Antibody Drug Conjugates Consumption by Top Countries
6.4.1 China Antibody Drug Conjugates Consumption Volume from 2016 to 2021
6.4.2 Japan Antibody Drug Conjugates Consumption Volume from 2016 to 2021
6.4.3 South Korea Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 7 Europe Antibody Drug Conjugates Market Analysis
7.1 Europe Antibody Drug Conjugates Consumption and Value Analysis
7.1.1 Europe Antibody Drug Conjugates Market Under COVID-19
7.2 Europe Antibody Drug Conjugates Consumption Volume by Types
7.3 Europe Antibody Drug Conjugates Consumption Structure by Application
7.4 Europe Antibody Drug Conjugates Consumption by Top Countries
7.4.1 Germany Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.2 UK Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.3 France Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.4 Italy Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.5 Russia Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.6 Spain Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.7 Netherlands Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.8 Switzerland Antibody Drug Conjugates Consumption Volume from 2016 to 2021
7.4.9 Poland Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 8 South Asia Antibody Drug Conjugates Market Analysis
8.1 South Asia Antibody Drug Conjugates Consumption and Value Analysis
8.1.1 South Asia Antibody Drug Conjugates Market Under COVID-19
8.2 South Asia Antibody Drug Conjugates Consumption Volume by Types
8.3 South Asia Antibody Drug Conjugates Consumption Structure by Application
8.4 South Asia Antibody Drug Conjugates Consumption by Top Countries
8.4.1 India Antibody Drug Conjugates Consumption Volume from 2016 to 2021
8.4.2 Pakistan Antibody Drug Conjugates Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Antibody Drug Conjugates Market Analysis
9.1 Southeast Asia Antibody Drug Conjugates Consumption and Value Analysis
9.1.1 Southeast Asia Antibody Drug Conjugates Market Under COVID-19
9.2 Southeast Asia Antibody Drug Conjugates Consumption Volume by Types
9.3 Southeast Asia Antibody Drug Conjugates Consumption Structure by Application
9.4 Southeast Asia Antibody Drug Conjugates Consumption by Top Countries
9.4.1 Indonesia Antibody Drug Conjugates Consumption Volume from 2016 to 2021
9.4.2 Thailand Antibody Drug Conjugates Consumption Volume from 2016 to 2021
9.4.3 Singapore Antibody Drug Conjugates Consumption Volume from 2016 to 2021
9.4.4 Malaysia Antibody Drug Conjugates Consumption Volume from 2016 to 2021
9.4.5 Philippines Antibody Drug Conjugates Consumption Volume from 2016 to 2021
9.4.6 Vietnam Antibody Drug Conjugates Consumption Volume from 2016 to 2021
9.4.7 Myanmar Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 10 Middle East Antibody Drug Conjugates Market Analysis
10.1 Middle East Antibody Drug Conjugates Consumption and Value Analysis
10.1.1 Middle East Antibody Drug Conjugates Market Under COVID-19
10.2 Middle East Antibody Drug Conjugates Consumption Volume by Types
10.3 Middle East Antibody Drug Conjugates Consumption Structure by Application
10.4 Middle East Antibody Drug Conjugates Consumption by Top Countries
10.4.1 Turkey Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.3 Iran Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.5 Israel Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.6 Iraq Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.7 Qatar Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.8 Kuwait Antibody Drug Conjugates Consumption Volume from 2016 to 2021
10.4.9 Oman Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 11 Africa Antibody Drug Conjugates Market Analysis
11.1 Africa Antibody Drug Conjugates Consumption and Value Analysis
11.1.1 Africa Antibody Drug Conjugates Market Under COVID-19
11.2 Africa Antibody Drug Conjugates Consumption Volume by Types
11.3 Africa Antibody Drug Conjugates Consumption Structure by Application
11.4 Africa Antibody Drug Conjugates Consumption by Top Countries
11.4.1 Nigeria Antibody Drug Conjugates Consumption Volume from 2016 to 2021
11.4.2 South Africa Antibody Drug Conjugates Consumption Volume from 2016 to 2021
11.4.3 Egypt Antibody Drug Conjugates Consumption Volume from 2016 to 2021
11.4.4 Algeria Antibody Drug Conjugates Consumption Volume from 2016 to 2021
11.4.5 Morocco Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 12 Oceania Antibody Drug Conjugates Market Analysis
12.1 Oceania Antibody Drug Conjugates Consumption and Value Analysis
12.2 Oceania Antibody Drug Conjugates Consumption Volume by Types
12.3 Oceania Antibody Drug Conjugates Consumption Structure by Application
12.4 Oceania Antibody Drug Conjugates Consumption by Top Countries
12.4.1 Australia Antibody Drug Conjugates Consumption Volume from 2016 to 2021
12.4.2 New Zealand Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 13 South America Antibody Drug Conjugates Market Analysis
13.1 South America Antibody Drug Conjugates Consumption and Value Analysis
13.1.1 South America Antibody Drug Conjugates Market Under COVID-19
13.2 South America Antibody Drug Conjugates Consumption Volume by Types
13.3 South America Antibody Drug Conjugates Consumption Structure by Application
13.4 South America Antibody Drug Conjugates Consumption Volume by Major Countries
13.4.1 Brazil Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.2 Argentina Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.3 Columbia Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.4 Chile Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.5 Venezuela Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.6 Peru Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Antibody Drug Conjugates Consumption Volume from 2016 to 2021
13.4.8 Ecuador Antibody Drug Conjugates Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Antibody Drug Conjugates Business
14.1 F. Hoffman-La Roche
14.1.1 F. Hoffman-La Roche Company Profile
14.1.2 F. Hoffman-La Roche Antibody Drug Conjugates Product Specification
14.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Novartis AG
14.2.1 Novartis AG Company Profile
14.2.2 Novartis AG Antibody Drug Conjugates Product Specification
14.2.3 Novartis AG Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Takeda Pharmaceutical
14.3.1 Takeda Pharmaceutical Company Profile
14.3.2 Takeda Pharmaceutical Antibody Drug Conjugates Product Specification
14.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Pfizer
14.4.1 Pfizer Company Profile
14.4.2 Pfizer Antibody Drug Conjugates Product Specification
14.4.3 Pfizer Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Seattle Genetics
14.5.1 Seattle Genetics Company Profile
14.5.2 Seattle Genetics Antibody Drug Conjugates Product Specification
14.5.3 Seattle Genetics Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Genentech
14.6.1 Genentech Company Profile
14.6.2 Genentech Antibody Drug Conjugates Product Specification
14.6.3 Genentech Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Immunogen
14.7.1 Immunogen Company Profile
14.7.2 Immunogen Antibody Drug Conjugates Product Specification
14.7.3 Immunogen Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Progenics Pharmaceuticals
14.8.1 Progenics Pharmaceuticals Company Profile
14.8.2 Progenics Pharmaceuticals Antibody Drug Conjugates Product Specification
14.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Bayer Healthcare Pharmaceuticals
14.9.1 Bayer Healthcare Pharmaceuticals Company Profile
14.9.2 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Product Specification
14.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Antibody Drug Conjugates Market Forecast (2022-2027)
15.1 Global Antibody Drug Conjugates Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Antibody Drug Conjugates Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Antibody Drug Conjugates Value and Growth Rate Forecast (2022-2027)
15.2 Global Antibody Drug Conjugates Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Antibody Drug Conjugates Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Antibody Drug Conjugates Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Antibody Drug Conjugates Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Antibody Drug Conjugates Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Antibody Drug Conjugates Consumption Forecast by Type (2022-2027)
15.3.2 Global Antibody Drug Conjugates Revenue Forecast by Type (2022-2027)
15.3.3 Global Antibody Drug Conjugates Price Forecast by Type (2022-2027)
15.4 Global Antibody Drug Conjugates Consumption Volume Forecast by Application (2022-2027)
15.5 Antibody Drug Conjugates Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Drug Temperature Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Small Molecule Drug CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
The Intelligent Drug Delivery Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Contract Drug Discovery Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Computer-assisted Drug Design Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
Executive Summary
Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Ant...
Executive Summary
Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Thir...